| Jacob Tyler Abel, MD | |
|
4805 Ne Glisan St, Portland, OR 97213-2933 | |
| (503) 215-6096 | |
| Not Available |
| Full Name | Jacob Tyler Abel |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 9 Years |
| Location | 4805 Ne Glisan St, Portland, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083095319 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | 4301116670 (Michigan) | Secondary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MD206032 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Portland Medical Center | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Oregon | 5395656284 | 102 |
News Archive
According to projections from the United States Census Bureau, people with skin of color will comprise approximately half of the U.S. population by 2050. This group, which includes African-Americans, Asians, Latinos and other ethnicities, are more prone to certain dermatologic problems than those with lighter skin tones due to their genetic make-up and in some cases cultural practices.
Night shift work was associated with women having an increased risk of breast, skin, and gastrointestinal cancer, according to a meta-analysis.
Regulus Therapeutics Inc. announced today that the United States Patent and Trademark Office has allowed claims in a patent application (US Serial No. 12/550,579) derived from the "Tuschl III" patent series. The allowed claims relate to human microRNA miR-155, a microRNA that is a potential target for immuno-inflammatory indications, and a lead program of the Regulus-GSK Strategic Alliance.
People in search of pain relief who take the generic anti-inflammatory etodolac suffer 60 percent fewer gastrointestinal complications than those who take similar drugs, according to researchers at UT Southwestern Medical Center at Dallas and the Dallas Veterans Affairs Medical Center.
Many parents are hesitant to use signs with their babies because they fear it will delay their child's verbal growth. However, research supports the use of symbolic gestures to foster language skills and verbal development.
› Verified 2 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003991845 PECOS PAC ID: 5395656284 Enrollment ID: O20031113000626 |
News Archive
According to projections from the United States Census Bureau, people with skin of color will comprise approximately half of the U.S. population by 2050. This group, which includes African-Americans, Asians, Latinos and other ethnicities, are more prone to certain dermatologic problems than those with lighter skin tones due to their genetic make-up and in some cases cultural practices.
Night shift work was associated with women having an increased risk of breast, skin, and gastrointestinal cancer, according to a meta-analysis.
Regulus Therapeutics Inc. announced today that the United States Patent and Trademark Office has allowed claims in a patent application (US Serial No. 12/550,579) derived from the "Tuschl III" patent series. The allowed claims relate to human microRNA miR-155, a microRNA that is a potential target for immuno-inflammatory indications, and a lead program of the Regulus-GSK Strategic Alliance.
People in search of pain relief who take the generic anti-inflammatory etodolac suffer 60 percent fewer gastrointestinal complications than those who take similar drugs, according to researchers at UT Southwestern Medical Center at Dallas and the Dallas Veterans Affairs Medical Center.
Many parents are hesitant to use signs with their babies because they fear it will delay their child's verbal growth. However, research supports the use of symbolic gestures to foster language skills and verbal development.
› Verified 2 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114015971 PECOS PAC ID: 9335057447 Enrollment ID: O20031117000153 |
News Archive
According to projections from the United States Census Bureau, people with skin of color will comprise approximately half of the U.S. population by 2050. This group, which includes African-Americans, Asians, Latinos and other ethnicities, are more prone to certain dermatologic problems than those with lighter skin tones due to their genetic make-up and in some cases cultural practices.
Night shift work was associated with women having an increased risk of breast, skin, and gastrointestinal cancer, according to a meta-analysis.
Regulus Therapeutics Inc. announced today that the United States Patent and Trademark Office has allowed claims in a patent application (US Serial No. 12/550,579) derived from the "Tuschl III" patent series. The allowed claims relate to human microRNA miR-155, a microRNA that is a potential target for immuno-inflammatory indications, and a lead program of the Regulus-GSK Strategic Alliance.
People in search of pain relief who take the generic anti-inflammatory etodolac suffer 60 percent fewer gastrointestinal complications than those who take similar drugs, according to researchers at UT Southwestern Medical Center at Dallas and the Dallas Veterans Affairs Medical Center.
Many parents are hesitant to use signs with their babies because they fear it will delay their child's verbal growth. However, research supports the use of symbolic gestures to foster language skills and verbal development.
› Verified 2 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093976243 PECOS PAC ID: 3476450560 Enrollment ID: O20031217000186 |
News Archive
According to projections from the United States Census Bureau, people with skin of color will comprise approximately half of the U.S. population by 2050. This group, which includes African-Americans, Asians, Latinos and other ethnicities, are more prone to certain dermatologic problems than those with lighter skin tones due to their genetic make-up and in some cases cultural practices.
Night shift work was associated with women having an increased risk of breast, skin, and gastrointestinal cancer, according to a meta-analysis.
Regulus Therapeutics Inc. announced today that the United States Patent and Trademark Office has allowed claims in a patent application (US Serial No. 12/550,579) derived from the "Tuschl III" patent series. The allowed claims relate to human microRNA miR-155, a microRNA that is a potential target for immuno-inflammatory indications, and a lead program of the Regulus-GSK Strategic Alliance.
People in search of pain relief who take the generic anti-inflammatory etodolac suffer 60 percent fewer gastrointestinal complications than those who take similar drugs, according to researchers at UT Southwestern Medical Center at Dallas and the Dallas Veterans Affairs Medical Center.
Many parents are hesitant to use signs with their babies because they fear it will delay their child's verbal growth. However, research supports the use of symbolic gestures to foster language skills and verbal development.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jacob Tyler Abel, MD Po Box 3395, Portland, OR 97208-3395 Ph: (507) 215-6023 | Jacob Tyler Abel, MD 4805 Ne Glisan St, Portland, OR 97213-2933 Ph: (503) 215-6096 |
News Archive
According to projections from the United States Census Bureau, people with skin of color will comprise approximately half of the U.S. population by 2050. This group, which includes African-Americans, Asians, Latinos and other ethnicities, are more prone to certain dermatologic problems than those with lighter skin tones due to their genetic make-up and in some cases cultural practices.
Night shift work was associated with women having an increased risk of breast, skin, and gastrointestinal cancer, according to a meta-analysis.
Regulus Therapeutics Inc. announced today that the United States Patent and Trademark Office has allowed claims in a patent application (US Serial No. 12/550,579) derived from the "Tuschl III" patent series. The allowed claims relate to human microRNA miR-155, a microRNA that is a potential target for immuno-inflammatory indications, and a lead program of the Regulus-GSK Strategic Alliance.
People in search of pain relief who take the generic anti-inflammatory etodolac suffer 60 percent fewer gastrointestinal complications than those who take similar drugs, according to researchers at UT Southwestern Medical Center at Dallas and the Dallas Veterans Affairs Medical Center.
Many parents are hesitant to use signs with their babies because they fear it will delay their child's verbal growth. However, research supports the use of symbolic gestures to foster language skills and verbal development.
› Verified 2 days ago
Dr. Kevin P Sargeant, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-8276 Fax: 503-494-2025 | |
Mary Jo Drew, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 3131 N. Vancouver Ave., American Red Cross Pnw Regional Blood Services, Portland, OR 97227 Phone: 503-528-5920 | |
Dr. Judith Ann Ray, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1015 Nw 22nd Ave, Portland, OR 97210 Phone: 503-413-8259 Fax: 503-413-6267 | |
Matthew Carstens Frank, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 9205 Sw Barnes Rd, Portland, OR 97225 Phone: 303-859-4275 | |
Sarah Walter, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1015 Nw 22nd Ave, Dept Of Pathology, Portland, OR 97210 Phone: 503-237-0507 | |
Matthew Evans, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1015 Nw 22nd Ave, Portland, OR 97210 Phone: 800-649-8730 |